Search research articles
Contact Us
Filters
Showing results (11-20 of 132) with videos related to
Page
of 14
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
November 18, 2011
HER2 testing in gastric and gastroesophageal junction cancers: a new therapeutic target and diagnostic challenge
David G Hicks, Christa Whitney-Miller
Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission
|
September 11, 2024
Optimized biomarker evaluation and molecular testing in the era of breast cancer precision medicine
David G Hicks, Bradley M Turner
Human Pathology
|
March 26, 2005
Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines
David G Hicks, Raymond R Tubbs
Archives of Pathology & Laboratory Medicine
|
October 9, 2014
College of American Pathologists Guidelines for Reporting HER2 Test Results in Gastric Cancer
Christa Whitney-Miller, David G Hicks
Archives of Pathology & Laboratory Medicine
|
July 30, 2016
In Reply
M Elizabeth H Hammond, David G Hicks
American Journal of Clinical Pathology
|
September 20, 2015
Core vs Breast Resection Specimen: Does It Make a Difference for HER2 Results?
David G Hicks, Patrick Fitzgibbons, Elizabeth Hammond
Journal of the National Cancer Institute. Monographs
|
June 16, 2011
Breast cancer predictive factor testing: the challenges and importance of standardizing tissue handling
David G Hicks, LeeAnn Kushner, Kristin McCarthy
Archives of Pathology & Laboratory Medicine
|
April 18, 2015
American Society of Clinical Oncology/College of American Pathologists Human Epidermal Growth Factor Receptor 2 Testing Clinical Practice Guideline Upcoming Modifications: Proof That Clinical Practice Guidelines Are Living Documents
M Elizabeth H Hammond, David G Hicks
The Breast Journal
|
April 12, 2019
Reconsidering "low-risk" criteria for breast cancer recurrence in hormone positive patients
Armen Soukiazian, David G Hicks, Bradley M Turner
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
August 26, 2009
Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?
Ping Tang, Kristin A Skinner, David G Hicks
Page
of 14
Search research articles
Search
Showing results (11-20 of 132) with videos related to
Sort By:
Page
of 14
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
November 18, 2011
HER2 testing in gastric and gastroesophageal junction cancers: a new therapeutic target and diagnostic challenge
David G Hicks, Christa Whitney-Miller
Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission
|
September 11, 2024
Optimized biomarker evaluation and molecular testing in the era of breast cancer precision medicine
David G Hicks, Bradley M Turner
Human Pathology
|
March 26, 2005
Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines
David G Hicks, Raymond R Tubbs
Archives of Pathology & Laboratory Medicine
|
October 9, 2014
College of American Pathologists Guidelines for Reporting HER2 Test Results in Gastric Cancer
Christa Whitney-Miller, David G Hicks
Archives of Pathology & Laboratory Medicine
|
July 30, 2016
In Reply
M Elizabeth H Hammond, David G Hicks
American Journal of Clinical Pathology
|
September 20, 2015
Core vs Breast Resection Specimen: Does It Make a Difference for HER2 Results?
David G Hicks, Patrick Fitzgibbons, Elizabeth Hammond
Journal of the National Cancer Institute. Monographs
|
June 16, 2011
Breast cancer predictive factor testing: the challenges and importance of standardizing tissue handling
David G Hicks, LeeAnn Kushner, Kristin McCarthy
Archives of Pathology & Laboratory Medicine
|
April 18, 2015
American Society of Clinical Oncology/College of American Pathologists Human Epidermal Growth Factor Receptor 2 Testing Clinical Practice Guideline Upcoming Modifications: Proof That Clinical Practice Guidelines Are Living Documents
M Elizabeth H Hammond, David G Hicks
The Breast Journal
|
April 12, 2019
Reconsidering "low-risk" criteria for breast cancer recurrence in hormone positive patients
Armen Soukiazian, David G Hicks, Bradley M Turner
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
August 26, 2009
Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?
Ping Tang, Kristin A Skinner, David G Hicks
Page
of 14